These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1343510)
21. The waking nightmare: an overview of obsessive compulsive disorder. Rapoport JL J Clin Psychiatry; 1990 Nov; 51 Suppl():25-8. PubMed ID: 2228991 [TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression. Power AC; Cowen PJ Mol Aspects Med; 1992; 13(3):205-20. PubMed ID: 1435104 [No Abstract] [Full Text] [Related]
23. Animal models in obsessive compulsive disorder. Olivier B Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():27-9. PubMed ID: 1517553 [No Abstract] [Full Text] [Related]
24. Role of serotonin in obsessive-compulsive disorder. Baumgarten HG; Grozdanovic Z Br J Psychiatry Suppl; 1998; (35):13-20. PubMed ID: 9829022 [TBL] [Abstract][Full Text] [Related]
25. Neurobiology confirms psychopathology. On the antagonism of psychosis and obsessive-compulsive syndromes. Zink M; Englisch S; Dressing H Psychopathology; 2008; 41(5):279-85. PubMed ID: 18594162 [TBL] [Abstract][Full Text] [Related]
26. [Neuroimaging and neurobiology of obsessive compulsive disorder: review of recent developments in research]. Huguelet P; McQuillan A Encephale; 1996; 22(1):41-5. PubMed ID: 8681874 [TBL] [Abstract][Full Text] [Related]
28. Schizo-obsessive and obsessive-compulsive disorder: comparison of clinical characteristics and neurological soft signs. Sevincok L; Akoglu A; Arslantas H Psychiatry Res; 2006 Dec; 145(2-3):241-8. PubMed ID: 17070933 [TBL] [Abstract][Full Text] [Related]
29. Psychophysiological and clinical value of event-related potentials in obsessive-compulsive disorder. Morault PM; Bourgeois M; Laville J; Bensch C; Paty J Biol Psychiatry; 1997 Jul; 42(1):46-56. PubMed ID: 9193741 [TBL] [Abstract][Full Text] [Related]
30. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety. Murphy DL; Pigott TA J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026 [TBL] [Abstract][Full Text] [Related]
31. Neurobiology of obsessive compulsive disorder: a review. Insel TR Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():31-3. PubMed ID: 1517554 [No Abstract] [Full Text] [Related]
32. The neuroethological approach to obsessive-compulsive disorder. Stein DJ; Shoulberg N; Helton K; Hollander E Compr Psychiatry; 1992; 33(4):274-81. PubMed ID: 1643870 [TBL] [Abstract][Full Text] [Related]
33. Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine. Simeon D; Hollander E; Stein DJ; DeCaria C; Cohen LJ; Saoud JB; Islam N; Hwang M Psychiatry Res; 1995 Sep; 58(2):161-4. PubMed ID: 8570768 [TBL] [Abstract][Full Text] [Related]
34. Serotonin: la chica de moda in biological psychiatry? Banki CM Biol Psychiatry; 1991 May; 29(10):949-52. PubMed ID: 2065139 [No Abstract] [Full Text] [Related]
35. Effects of fenfluramine on plasma HVA in OCD. Hollander E; Stein DJ; Saoud JB; DeCaria CM; Cooper TB; Trungold S; Stanley M; Liebowitz MR Psychiatry Res; 1992 May; 42(2):185-8. PubMed ID: 1631253 [No Abstract] [Full Text] [Related]
36. Has OCD research gone to the dogs? Comments on "Recent advances in obsessive-compulsive disorder". Insel TR Neuropsychopharmacology; 1991 Aug; 5(1):13-7; discussion 21-2. PubMed ID: 1930607 [No Abstract] [Full Text] [Related]